Annovis Bio, Inc.
XNYS:ANVS
5.12
$5.43 - 160.00
$5.00 - 5.00
$4.9
$5.5
$5
$4.92
7.39
1.11
1291677
7005831
22392909.78
Chart
TendieTensor AI Analysis
Company
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Fundamentals
6
-3.440000
7.825810
-0.37
100
BBG00PN9XD40
BBG00PN9XDJ4
19.49M
26.11M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ANVS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.